Ascites Market 2032: Epidemiology Review, Pipeline Breakthroughs, Regulatory Highlights by DelveInsight | AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG

DelveInsight's "Ascites Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Ascites market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ascites Market Forecast
https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Ascites Market Report:
• The Ascites market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In December 2023, The lead candidate OCE-205 from Ocelot Bio has been designated as an orphan drug by the US Food and Drug Administration (FDA) for the treatment of ascites, with the exception of cases associated with cancer. Orphan drug designation is typically granted to therapies addressing rare diseases or conditions affecting fewer than 200,000 individuals in the United States.
• In the 7MM, there were approximately 242,201 cases of ascites caused by cirrhosis in 2021. These cases are anticipated to rise at a respectable CAGR from 2019 to 2032, according to estimations from DelveInsight
• There were over 150,291 occurrences of ascites caused by cirrhosis in the US in 2021. According to the malignancy, there were 8,683, 3,621, 12,820, and 10,454 instances of ascites from ovarian, stomach, breast, and colorectal cancer in the US in 2021, respectively
• Ascites caused by cirrhosis are estimated to have occurred in 20,104 instances in Germany in 2021. Ascites cases related to ovarian, stomach, breast, and colorectal cancer were reported to be 5,009, 1,914, 3,495, and 3,888 in Germany in 2021, respectively
• Key Ascites Companies: AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Merit Medical Systems Inc., Neovii Pharmaceuticals AG, GI Supply, BioVie, Ocelot Bio, Movetis, Sanofi, Otsuka Beijing Research Institute, Grifols Therapeutics LLC, Norgine, and others
• Key Ascites Therapies: BIV201 (Terlipressin), OCE-205, catumaxomab, M0002, satavaptan (SR121463B), Tolvaptan, Albumin, Rifaximin, and others
• The Ascites market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Ascites pipeline products will significantly revolutionize the Ascites market dynamics.

Ascites Overview
Ascites is a medical condition characterized by an abnormal accumulation of fluid in the abdominal cavity. This fluid buildup leads to abdominal swelling or distension. Ascites can develop as a result of various underlying health conditions, most commonly liver disease, but it can also occur due to heart failure, kidney disease, cancer, or infection.

Get a Free sample for the Ascites Market Report:
https://www.delveinsight.com/report-store/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ascites Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Ascites Epidemiology Segmentation:
The Ascites market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Ascites
• Prevalent Cases of Ascites by severity
• Gender-specific Prevalence of Ascites
• Diagnosed Cases of Episodic and Chronic Ascites

Download the report to understand which factors are driving Ascites epidemiology trends @ Ascites Epidemiology Forecast
https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ascites Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ascites market or expected to get launched during the study period. The analysis covers Ascites market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Ascites Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Ascites Therapies and Key Companies
• BIV201 (Terlipressin): BioVie
• OCE-205: Ocelot Bio

Discover more about therapies set to grab major Ascites market share @ Ascites Treatment Market
https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Ascites Market Strengths
• The rise in the patient population of underlying conditions of ascites such as liver cirrhosis, alcoholism, kidney or heart failure, malignancy, etc. might contribute to an increase in the patient population of ascites

Ascites Market Opportunities
• Limited approved, and emerging therapies in the pipeline offer a great opportunity for the investment and development of novel therapies

Scope of the Ascites Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Ascites Companies: AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter International Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Merit Medical Systems Inc., Neovii Pharmaceuticals AG, GI Supply, BioVie, Ocelot Bio, Movetis, Sanofi, Otsuka Beijing Research Institute, Grifols Therapeutics LLC, Norgine, and others
• Key Ascites Therapies: BIV201 (Terlipressin), OCE-205, catumaxomab, M0002, satavaptan (SR121463B), Tolvaptan, Albumin, Rifaximin, and others
• Ascites Therapeutic Assessment: Ascites current marketed and Ascites emerging therapies
• Ascites Market Dynamics: Ascites market drivers and Ascites market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Ascites Unmet Needs, KOL's views, Analyst's views, Ascites Market Access and Reimbursement

To know more about Ascites companies working in the treatment market, visit @ Ascites Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Ascites Market Report Introduction
2. Executive Summary for Ascites
3. SWOT analysis of Ascites
4. Ascites Patient Share (%) Overview at a Glance
5. Ascites Market Overview at a Glance
6. Ascites Disease Background and Overview
7. Ascites Epidemiology and Patient Population
8. Country-Specific Patient Population of Ascites
9. Ascites Current Treatment and Medical Practices
10. Ascites Unmet Needs
11. Ascites Emerging Therapies
12. Ascites Market Outlook
13. Country-Wise Ascites Market Analysis (2019-2032)
14. Ascites Market Access and Reimbursement of Therapies
15. Ascites Market Drivers
16. Ascites Market Barriers
17. Ascites Appendix
18. Ascites Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Ascites Pipeline https://www.delveinsight.com/report-store/ascites-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Ascites Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Ascites market. A detailed picture of the Ascites pipeline landscape is provided, which includes the disease overview and Ascites treatment guidelines.

Latest Reports by DelveInsight

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.

Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.